| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/19/1999 | CA2061607C 1-biphenylimidazole derivatives, their preparation and their therapeutic use |
| 01/19/1999 | CA2037663C Use of complexes and chelates resp., of antibiotics with bivalent and/or trivalent metals in the obtaining of anti-ulcer drugs, new complexes and chelates resp., of antibiotics with bivalent and/trivalent metals and processes for the obtaining thereof |
| 01/19/1999 | CA2003326C Bone marrow suppressing agents |
| 01/19/1999 | CA2002105C Dideoxy-l-arabinitol derivatives as antiviral compounds |
| 01/18/1999 | CA2254411A1 Ticlopidine hcl formulations |
| 01/18/1999 | CA2237160A1 Gida1 |
| 01/18/1999 | CA2237050A1 Histidine kinase |
| 01/18/1999 | CA2237043A1 Response regulator |
| 01/16/1999 | CA2240976A1 Novel seco compounds from the class of tylosins |
| 01/14/1999 | WO1999001579A1 Compositions and methods for the delivery of oligonucleotides via the alimentary canal |
| 01/14/1999 | WO1999001467A2 Therapeutically active compounds with low systemic activity due to reduce half life |
| 01/14/1999 | WO1999001463A2 Modified glycosides, compositions comprised thereof and methods of use thereof |
| 01/14/1999 | WO1999001458A1 Crystalline macrolides and process for their preparation |
| 01/14/1999 | WO1999001455A1 Compounds |
| 01/14/1999 | WO1999001454A1 Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders |
| 01/14/1999 | WO1999001452A1 Novel cycloalkyl substituted imidazoles |
| 01/14/1999 | WO1999001451A1 Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists |
| 01/14/1999 | WO1999001450A1 POLYMORPHS OF 8-CHLORO-6, 11-DIHYDRO-11- (4-PIPERIDYLIDENE) -5H-BENZO[5,6] CYCLOHEPTA[1,2-b]PYRIDINE |
| 01/14/1999 | WO1999001449A1 2-substituted 4,5-diaryl imidazoles |
| 01/14/1999 | WO1999001448A1 5-(2-ethyl-2h-tetrazol-5-y1)-1-methyl-1,2,3,6-tetrahydropyridine maleate |
| 01/14/1999 | WO1999001447A1 Diaminorhodamine derivatives |
| 01/14/1999 | WO1999001444A1 Polymorphic form of the tachykinin receptor antagonist 2-(r)-(1-(r) -(3,5-bis(trifluoromethyl) phenyl)ethoxy)-3-(s)-(4-fluoro) phenyl-4-(3-5 (-oxo-1h,4h-1,2,4,-triazolo) methylmorpholine |
| 01/14/1999 | WO1999001439A1 Aryl-and arylamino-substituted heterocycles as corticotropin releasing hormone antagonists |
| 01/14/1999 | WO1999001438A1 New compounds |
| 01/14/1999 | WO1999001437A1 Compounds |
| 01/14/1999 | WO1999001435A1 (1h-imidazol-4-yl)piperidine derivatives, preparation and application in therapy |
| 01/14/1999 | WO1999001434A1 Inhibitors of farnesyl protein transferase |
| 01/14/1999 | WO1999001430A1 Method for preparing a substituted perhydroisoindole |
| 01/14/1999 | WO1999001428A1 Hydrazine derivatives |
| 01/14/1999 | WO1999001427A2 Novel nitric oxide-releasing amidine- and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same |
| 01/14/1999 | WO1999001426A1 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as mek inhibitors |
| 01/14/1999 | WO1999001421A1 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as mek inhibitors |
| 01/14/1999 | WO1999001417A1 (S) 2-METHYLAMINO-2-PHENYL-n-BUTYL 3,4,5-TRIMETHOXYBENZOATE, ITS APPLICATION TO THE TREATMENT OF CHRONIC PAIN |
| 01/14/1999 | WO1999001416A2 1-amino-alkylcyclohexane nmda receptor antagonists |
| 01/14/1999 | WO1999001158A1 Improved method for transferring nucleic acid into the striped muscle and combination therefor |
| 01/14/1999 | WO1999001154A1 Method for inhibiting immunostimulatory dna associated responses |
| 01/14/1999 | WO1999001149A1 Health supplement |
| 01/14/1999 | WO1999001148A1 Pharmaceutical composition containing polyphenols from grapes, in particular resveratrol, and yeast extracts |
| 01/14/1999 | WO1999001141A1 Use of dextran and other polysaccharides to improve mucus clearance |
| 01/14/1999 | WO1999001138A1 A pharmaceutical formulation of uridine triphosphate suitable for administration in a small volume |
| 01/14/1999 | WO1999001137A1 Azelastine hydrochloride-containing percutaneous preparation having good percutaneous absorbability and reduced skin irritation |
| 01/14/1999 | WO1999001136A1 Novel substituted imidazole compounds |
| 01/14/1999 | WO1999001135A1 Pharmaceutical compositions containing eletriptan hemisulphate and caffeine |
| 01/14/1999 | WO1999001134A1 Inhibitors of the phosphodiesterase-4 for the treatment of allergic rhinitis |
| 01/14/1999 | WO1999001133A1 Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin |
| 01/14/1999 | WO1999001132A1 Medicine containing yohimbine and arginine for treating erectile dysfunction |
| 01/14/1999 | WO1999001131A1 Novel substituted imidazole compounds |
| 01/14/1999 | WO1999001130A1 Novel substituted imidazole compounds |
| 01/14/1999 | WO1999001128A1 Certain diarylimidazole derivatives; a new class of npy specific ligands |
| 01/14/1999 | WO1999001127A1 Compounds and methods |
| 01/14/1999 | WO1999001126A1 Pharmaceutical compositions comprising alkanoyl l-carnitine in combination with a statine for treating pathologies brought about by an altered lipid metabolism |
| 01/14/1999 | WO1999001125A1 A pharmaceutical composition containing kynurenine and thymine or tryptophan and thymine |
| 01/14/1999 | WO1999001124A1 Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| 01/14/1999 | WO1999001123A1 Low dosed 15-desoxyspergualine preparations |
| 01/14/1999 | WO1999001122A1 Delayed-release dosage forms of sertraline |
| 01/14/1999 | WO1999001121A1 Sertraline salts and sustained-release dosage forms of sertraline |
| 01/14/1999 | WO1999001120A1 Solubilized sertraline compositions |
| 01/14/1999 | WO1999001119A1 Antiallergic agents |
| 01/14/1999 | WO1999001118A2 Antioxidant enhancement of therapy for hyperproliferative conditions |
| 01/14/1999 | WO1999001117A2 Inhibitors of nf-kappab as activators of hsf and inducers of heat shock proteins |
| 01/14/1999 | WO1999001116A1 Transdermal therapeutic system (tts) for administering sexual steroid hormones |
| 01/14/1999 | WO1999001115A1 Colon selective drug delivery composition |
| 01/14/1999 | WO1999001114A1 Prolonged anesthesia in joints and body spaces |
| 01/14/1999 | WO1999001113A1 Gelatine encapsulated solution dosage forms of sertraline |
| 01/14/1999 | WO1999001112A1 Multiple unit effervescent dosage form |
| 01/14/1999 | WO1999001111A1 Stabilized sustained release tramadol formulations |
| 01/14/1999 | WO1999001110A1 Targeted liposomal constructs for diagnostic and therapeutic uses |
| 01/14/1999 | WO1999001109A2 Therapeutical system for transdermal delivery of levonorgestrel |
| 01/14/1999 | WO1999001044A1 Palatable elemental medical food |
| 01/14/1999 | WO1999001033A1 Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds |
| 01/14/1999 | WO1998051311A3 Dihydropyrimidines and uses thereof |
| 01/14/1999 | WO1998049315A3 Combinatorial polyketide libraries produced using a modular pks gene cluster as scaffold |
| 01/14/1999 | WO1998045276A3 4,4-disubstituted-3,4-dihydro-2(1h)-quinazolinones useful as hiv reverse transcriptase inhibitors |
| 01/14/1999 | WO1998042729A3 Steroid sulfamates, method for the production and use thereof |
| 01/14/1999 | WO1998038986A3 Use of carvedilol or derivatives thereof for the manufacture of a medicament for the prevention and treatment of viral infections |
| 01/14/1999 | WO1998034917A3 Synthesis of acyclic nucleoside derivatives |
| 01/14/1999 | DE19830167A1 New aza:tyrosine derivatives |
| 01/14/1999 | DE19729879A1 Lagerstabile ophthalmische Zusammensetzungen, umfassend Diclofenac und Ofloxacin A storage stable ophthalmic compositions comprising diclofenac and ofloxacin |
| 01/14/1999 | DE19729810A1 Mittel zur Sepsistherapie, seine Herstellung und seine Verwendung Means for sepsis therapy, its preparation and its use |
| 01/14/1999 | DE19729487A1 Verfahren zur Herstellung von Wirkstoff-Zubereitungen mit kontrollierter Freisetzung aus einer Matrix A process for producing active ingredient compositions with controlled release from a matrix |
| 01/14/1999 | DE19729140A1 Use of non-peptide bradykinin antagonist in treating Alzheimer's disease |
| 01/14/1999 | DE19729134A1 Agent for treatment of HIV infections |
| 01/14/1999 | DE19728996A1 Triazolverbindungen und deren Verwendung Triazole compounds and the use thereof |
| 01/14/1999 | CA2615842A1 Polymorphs of 8-chloro-6,11-dihydro-11-(4-piperidylidene)-5h-benzo[5,6]cyclohepta[1,2-b]pyridine |
| 01/14/1999 | CA2297791A1 Health supplement |
| 01/14/1999 | CA2296014A1 Aryl-and arylamino-substituted heterocycles as corticotropin releasing hormone antagonists |
| 01/14/1999 | CA2295916A1 Medicine containing yohimbine and arginine for treating erectile dysfunction |
| 01/14/1999 | CA2295880A1 Diaminorhodamine derivatives |
| 01/14/1999 | CA2295762A1 Novel cycloalkyl substituted imidazoles |
| 01/14/1999 | CA2295748A1 Pharmaceutical compositions comprising alkanoyl l-carnitine in combination with a statine for treating pathologies brought about by an altered lipid metabolism |
| 01/14/1999 | CA2295720A1 Transdermal therapeutic system (tts) for administering sexual steroid hormones |
| 01/14/1999 | CA2295228A1 Novel substituted imidazole compounds |
| 01/14/1999 | CA2295062A1 Hydrazine derivatives |
| 01/14/1999 | CA2294988A1 Compositions and methods for the delivery of oligonucleotides via the alimentary canal |
| 01/14/1999 | CA2294900A1 Targeted liposomal constructs for diagnostic and therapeutic uses |
| 01/14/1999 | CA2294898A1 Certain diarylimidazole derivatives; a new class of npy specific ligands |
| 01/14/1999 | CA2294882A1 Compounds |
| 01/14/1999 | CA2294793A1 Improved method for transferring nucleic acid into the striped muscle and combination therefor |
| 01/14/1999 | CA2294785A1 Low dosed 15-desoxyspergualine preparations |
| 01/14/1999 | CA2294770A1 Compounds and methods |